文献速递银屑病与炎症性皮肤病

银屑病患者炎症性肠病的发病率与风险——一项全国性20年队列研究

Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study.
PubMed 文献 · J Invest Dermatol · 2018-08-18

该研究基于丹麦全国20年队列,纳入235,038例成人银屑病患者及1:1匹配对照,随访期间不足1%的银屑病患者发生克罗恩病(CD)或溃疡性结肠炎(UC)。银屑病与CD和UC风险升高相关,调整后风险比因治疗类型而异,性别和银屑病关节炎是特定风险因素。

要点

  • 银屑病患者随访期间CD或UC发生率均不足1%。
  • 局部治疗者CD调整HR为1.84,系统非生物治疗者为2.38。
  • UC调整HR:局部治疗1.49,系统非生物治疗1.51,生物治疗1.23(P=0.7197)。

核心结论

  • 银屑病与克罗恩病和溃疡性结肠炎风险升高相关,性别和银屑病关节炎是特定风险因素。

研究设计与样本

  • 全国性20年队列研究,纳入235,038例丹麦成人银屑病患者及1:1匹配的参照组。

主要发现

  • 随访期间不足1%的银屑病患者发生克罗恩病或溃疡性结肠炎。
  • 克罗恩病发病率在年轻女性银屑病患者和合并银屑病关节炎的患者中最高,男性银屑病患者溃疡性结肠炎发病率较非银屑病同龄人尤其高。
  • 克罗恩病调整风险比:局部治疗者1.84(95%CI 1.47-2.29),系统非生物治疗者2.38(95%CI 1.62-3.49);生物治疗期间无明确克罗恩病病例发生。
  • 溃疡性结肠炎调整风险比:局部治疗者1.49(95%CI 1.29-1.72),系统非生物治疗者1.51(95%CI 1.14-2.01),生物治疗者1.23(95%CI 0.39-3.86,P=0.7197)。
  • 银屑病患者克罗恩病(而非溃疡性结肠炎)诊断时间较一般人群显著更长,接受系统治疗者克罗恩病和溃疡性结肠炎诊断时间最长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In psoriasis patients, incidence rates of Crohn disease (CD) and ulcerative colitis (UC) have been increased in epidemiological studies and certain clinical trials, yet the association remains poorly understood. We studied a 20-year nationwide cohort of 235,038 Danish adults with psoriasis and a 1:1 matched reference group. Less than 1% of psoriasis patients developed CD or UC during follow-up. Incidence rates of CD were highest for younger women with psoriasis and patients with concurrent psoriatic arthritis, whereas men with psoriasis had particularly high incidence rates of UC compared with their non-psoriasis peers. Adjusted hazard ratios of CD were 1.84 (95% confidence interval [CI]= 1.47-2.29) and 2.38 (95% CI = 1.62-3.49) among psoriasis patients treated with topical and systemic nonbiologic therapy, respectively. No definite CD cases occurred during biologic therapy. For UC, adjusted hazard ratios were 1.49 (95% CI = 1.29-1.72), 1.51 (95% CI = 1.14-2.01), and 1.23 (95% CI = 0.39-3.86, P = 0.7197) for psoriasis patients receiving topical, systemic nonbiologic, and biologic therapy, respectively. Time to CD (but not UC) diagnosis was significantly longer for psoriasis patients compared with the general population, and patients receiving systemic treatment had the longest time to CD and UC. Psoriasis was associated with increased risk of CD and UC. Particular risk factors included sex and psoriatic arthritis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Egeberg A, Thyssen JP, Burisch J, et al. Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study. J Invest Dermatol. 2018. PMID: 30130618. doi:10.1016/j.jid.2018.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。